Overview
Updated 14 Jul 2026
Christopher Sayed, MD, is Professor, Department of Dermatology at University of North Carolina at Chapel Hill School of Medicine. The public record shows 171 publications with 2,735 citations (h-index 21), centered on Acne / Hidradenitis. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 14 companies, 2 NIH-funded awards (2020–2025).
- Most recent indexed publication: 2026 · The patient
- Top research focus: Acne / Hidradenitis
- 3 registered trials on ClinicalTrials.gov
- Open Payments reporting from 14 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 29 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- Anifrolumab for Hidradenitis Suppurativa
Sponsor: University of North Carolina, Chapel Hill
InvestigatorPhase 2Active, not recruitingNCT06374212 - Wet-to-dry vs Petrolatum & Non-stick Dressings After Hidradenitis Suppurativa Surgery
Sponsor: University of North Carolina, Chapel Hill
InvestigatorCompletedNCT05194969 - A Randomized Controlled Trial Evaluating the Efficacy of Intralesional Triamcinolone in Hidradenitis Suppurativa.
Sponsor: University of North Carolina, Chapel Hill
InvestigatorCompletedNCT02781818
Industry payments
Updated 14 Jul 2026
14 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202563 payments$111,977openpaymentsdata.cms.gov ↗
- UCB, Inc.Program year202510 payments$17,596openpaymentsdata.cms.gov ↗
- UCB SAProgram year20255 payments$13,355openpaymentsdata.cms.gov ↗
NIH funding
Updated 14 Jul 2026
2 NIH research awards on record, funded 2020–2025 per NIH RePORTER. The latest:
- Determining the Genetic Basis of Hidradenitis Suppurativa
Univ of North Carolina Chapel Hill
FY2025$395,810R01AR083790 - Determining the Genetic Basis of Hidradenitis Suppurativa
Univ of North Carolina Chapel Hill
FY2024$459,879R01AR083790 - Evaluation of the Genetics of Hidradenitis Suppurativa
Univ of North Carolina Chapel Hill
FY2021$136,576R21AR075996
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- The role of surgery in hidradenitis suppurativa: Expert-based holistic approaches.
Clinical and experimental dermatology
2026 - Genomic loci and molecular genetic mechanisms for hidradenitis suppurativa.
The British journal of dermatology
2025 - Safety and efficacy of biologics in patients with Down syndrome and hidradenitis suppurativa: a retrospective cohort study.
Clinical and experimental dermatology
2025
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
410 Market Street, Suite 400, Chapel Hill, NC 27516
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- M.D.
University of North Carolina at Chapel Hill
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗ - Internal Medicine Internship
University of North Carolina at Chapel Hill
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗ - Dermatology Residency
University of North Carolina at Chapel Hill
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗ - Board Certified
Dermatology (American Board of Dermatology)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
Editorial & leadership rolesjournal and society appointments
- Director
Hidradenitis Suppurativa Clinic, UNC Chapel Hill
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗ - Vice President
Hidradenitis Suppurativa Foundation
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hs-foundation.org ↗ - Site Principal Investigator
industry- and NIH-funded HS clinical trials (e.g., BE HEARD I/II bimekizumab studies)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
Secondary affiliationsappointments beyond the home institution
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unchealth.org ↗
Media & interviewspress, podcasts and appearances
- "Bimekizumab and Unmet Needs of Patients with HS, with Christopher J. Sayed, MD"
video interview, HCPLive
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hcplive.com ↗ - "Advances in HS treatment with Chris Sayed, MD"
video interview, Dermatology Times
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dermatologytimes.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dermatologytimes.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/christoph-sayed-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by otherswhere others cite or feature them
- Apple Podcasts
podcasts.apple.com/us/podcast/derms-on-drugs/id1793832955
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗ - Other
hs-foundation.org/christopher-sayed-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hs-foundation.org ↗ - Other
webmd.com/podcasts/20251030/when-your-hs-treatments-stop-working-finding-new-paths-to-relief
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →webmd.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Stephanie Davis, MD
University of North Carolina at Chapel Hill
- 393
- publications
- 58
- h-index
- 10
- trials
David Wohl, MD
University of North Carolina at Chapel Hill
- 471
- publications
- 57
- h-index
- 10
- trials
Jennifer Flythe, MD
University of North Carolina at Chapel Hill
- 205
- publications
- 43
- h-index
- 6
- trials
Anil Gehi, MD
University of North Carolina at Chapel Hill
- 192
- publications
- 33
- h-index
- 5
- trials